+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Management of dyslipidemia in HIV-infected patients

Management of dyslipidemia in HIV-infected patients

Mmw Fortschritte der Medizin 154(Suppl. 1): 34-36

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 054241535

Download citation: RISBibTeXText

PMID: 22916597

Related references

Dyslipidemia and lipid management in HIV-infected patients. Current Opinion in Endocrinology, Diabetes, and Obesity 18(2): 144-147, 2011

The evaluation and management of dyslipidemia in HIV-infected patients. Aids Clinical Care 13(12): 113-7, 120, 2002

Cardiovascular risk and dyslipidemia management in HIV-infected patients. Topics in Antiviral Medicine 20(4): 129-33; Quiz 123-4, 2013

Management of dyslipidemia and other cardiovascular risk factors in HIV-infected patients: case-based review. Topics in HIV Medicine 14(4): 134-139, 2006

Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study. HIV Clinical Trials 8(2): 77-85, 2007

Evaluation and pharmacologic management of the HIV-infected patient with dyslipidemia. Journal of the Association of Nurses in Aids Care 21(5): 429-438, 2010

Clinical management considerations for dyslipidemia in HIV-infected individuals. Postgraduate Medicine 124(1): 31-40, 2012

Coronary heart disease risk, dyslipidemia, and management in HIV-infected persons. HIV Clinical Trials 5(6): 416-433, 2005

Dyslipidemia among HIV-infected patients. Annals of African Medicine 13(3): 142, 2014

Treatment of dyslipidemia in HIV-infected patients. Expert Opinion on PharmacoTherapy 11(11): 1845-1854, 2010

Prevalence of dyslipidemia and dysglycaemia in HIV infected patients. East African Medical Journal 85(1): 10-17, 2008

Dyslipidemia in HIV-infected patients A new population in coronary risk?. European Heart Journal 23(Abstract Suppl.): 566, August-September, 2002

Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. Journal of Infection 50(4): 331-337, 2005

Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort. Open Aids Journal 2: 26-38, 2008

High frequency of dyslipidemia in VIH-infected patients in aa peruvian public hospital. Revista Peruana de Medicina Experimental Y Salud Publica 34(2): 239-244, 2018